Conversion strategies with chemotherapy plus targeted agents for colorectal cancer liver-only metastases: A systematic review
There is no consensus on the optimal systemic conversion therapy in patients with unresectable colorectal cancer liver-only metastases (CRLM) to achieve a complete resection. Interpretation of trials is complicated by heterogeneity of patients caused by emerging prognostic and predictive characteristics, such as RAS/BRAF mutation status, lack of consensus on unresectability criteria and lack of data on clinical outcome of secondary resections. A systematic review was performed of characteristics of study populations and methodology of trials regarding patients with initially unresectable colorectal cancer liver-only metastases.
Source: European Journal of Cancer - Category: Cancer & Oncology Authors: Karen Bolhuis, Milan Kos, Martijn G.H. van Oijen, Rutger-Jan Swijnenburg, Cornelis J.A. Punt Tags: Review Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Colorectal Cancer | Liver | Study | Urology & Nephrology